Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 6 | Immunity & Ageing

Fig. 6

From: B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice

Fig. 6

Mouse TC+Tg B-lymphoma/leukemia IgVH list. TC+Tg C.B17 mice generated CLL tumors were previously published [24], then, found mouse V1 generated tumor is slightly similar with human V1-46, and mouse V12, V2, and V3 generated tumor are similar with human V4-59. Mouse V7, V11, V6, V4, V5 generated tumors are each different in human V3. Higher TC+Tg tumors (V1-55, V1-52, V12-3, V2-9) are with mouse non-mutated B-1 B cell origin

Back to article page